Industry Focus Areas, Medical, Regulations
March 14, 2019
Via: Mass DeviceAerie Pharmaceuticals (NSDQ:AERI) said this week that the FDA approved the company’s once-daily eye drop Rocklatan for the treatment of elevated intraocular pressure in people with open-angle glaucoma or ocular hypertension. The Durham, N.C.-based company’s product is a fixed-dose combination […]
July 9, 2024
June 25, 2024